Valued at $30.0M at its early-stage round, Nov 2025. Nothing has traded since.
- ·Watch Response Pharmaceuticals: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Response Pharmaceuticals funding history
2 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jun 2024 | Debt | $3.9M | ▮ | ▮ |
| Feb 2022 | Early Stage VC | $8.0M | ▮ | ▮ |
Membership and data by Private Market View
Response Pharmaceuticals valuation
Response Pharmaceuticals was valued at $30 million at its early-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Response Pharmaceuticals raised?
Response Pharmaceuticals has raised $16.9 million in total; 2 of its rounds are on record. The largest on record was an $8 million early-stage round in Feb 2022; the most recent was a $3.9 million debt round in Jun 2024.
Response Pharmaceuticals has filed 3 Form Ds with the SEC since 2022, most recently in Jun 2024 ($3.9 million sold to 51 investors).
How Response Pharmaceuticals's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Response Pharmaceuticals, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Response Pharmaceuticals
- What is Response Pharmaceuticals worth?
- Response Pharmaceuticals is valued at $30.0M as of Oct 2026. Valued at $30.0M at its early-stage round, Nov 2025. Nothing has traded since.
- How much has Response Pharmaceuticals raised?
- Response Pharmaceuticals has raised $16.9M in total funding across 2 recorded rounds.
- When did Response Pharmaceuticals last raise?
- Response Pharmaceuticals last raised in Jun 2024 (Debt), raising $3.9M.